21 May 2013
Keywords: fda, warns, gsk, over, misleading, coreg, data
Article | 14 February 2005
In a warning letter issued to UK drugmaker GlaxoSmithKline, the US Food and Drug Administration said that the company presented ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 February 2005
© 2013 thepharmaletter.com